Statins to Prevent Rheumatoid Arthritis (STAPRA)
- Conditions
- Rheumatoid arthritis, RA, Arthralgia, Atorvastatin, seropositive, ACPA, RF, preventionreumatoide arthritis, artralgie, atorvastatine, seropositief, preventie
- Registration Number
- NL-OMON19910
- Lead Sponsor
- Amsterdam Rheumatology & immunology Center | Reade
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 220
Inclusion Criteria
1) Age >= 18 years
2) Seropositive
Exclusion Criteria
1) Patients with synovitis during clinical examination (any of 44 joints of DAS) at inclusion or synovitis in the past during clinical examination by a rheumatologist.
2) Patients with typical RA erosions on X-rays of hand and feet.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The occurrence of clinical arthritis confirmed by a rheumatologist participating in the study.
- Secondary Outcome Measures
Name Time Method Effect on improvement of lipid profile, (sub)clinical CV risk, inflammatory parameters and changes in cIMT and arterial stiffness.